nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A metabolic perspective of late onset Alzheimer’s disease
|
Ettcheto, Miren |
|
2019 |
145 |
C |
p. |
artikel |
2 |
Atria-selective antiarrhythmic drugs in need of alliance partners
|
Peyronnet, Rémi |
|
2019 |
145 |
C |
p. |
artikel |
3 |
Comments on: “Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan”
|
Salvador-Martiín, Sara |
|
2019 |
145 |
C |
p. |
artikel |
4 |
Comments on: “Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan”
|
Riera, Pau |
|
2019 |
145 |
C |
p. |
artikel |
5 |
Drug-induced liver steatosis in patients with HIV infection
|
Gervasoni, Cristina |
|
2019 |
145 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
2019 |
145 |
C |
p. |
artikel |
7 |
Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions
|
de Brito Alves, José Luiz |
|
2019 |
145 |
C |
p. |
artikel |
8 |
Involvement of the GABAA receptor α subunit in the mode of action of etifoxine
|
Mattei, César |
|
2019 |
145 |
C |
p. |
artikel |
9 |
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis
|
Zhou, Pan |
|
2019 |
145 |
C |
p. |
artikel |
10 |
Natural products as a potential modulator of microglial polarization in neurodegenerative diseases
|
Jin, Xin |
|
2019 |
145 |
C |
p. |
artikel |
11 |
Ononin, sec-O-β-d-glucosylhamaudol and astragaloside I: antiviral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary
|
Yu, Yunru |
|
2019 |
145 |
C |
p. |
artikel |
12 |
Parthenolide, a feverfew-derived phytochemical, ameliorates obesity and obesity-induced inflammatory responses via the Nrf2/Keap1 pathway
|
Kim, Chae Young |
|
2019 |
145 |
C |
p. |
artikel |
13 |
Pharmacological actions and therapeutic potentials of bilirubin in islet transplantation for the treatment of diabetes
|
Yao, Qing |
|
2019 |
145 |
C |
p. |
artikel |
14 |
Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge
|
Chen, Xiuping |
|
2019 |
145 |
C |
p. |
artikel |
15 |
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies
|
Sanarica, F. |
|
2019 |
145 |
C |
p. |
artikel |
16 |
Pterostilbene: Mechanisms of its action as oncostatic agent in cell models and in vivo studies
|
Ma, Zhiqiang |
|
2019 |
145 |
C |
p. |
artikel |
17 |
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants
|
Fender, Anke C. |
|
2019 |
145 |
C |
p. |
artikel |
18 |
The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis
|
Ahmad, Akbar |
|
2019 |
145 |
C |
p. |
artikel |
19 |
The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis
|
Alwhaibi, Abdulrahman |
|
2019 |
145 |
C |
p. |
artikel |
20 |
Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
|
Shergold, Amy L. |
|
2019 |
145 |
C |
p. |
artikel |